The WHO framework to prepare for Country Introduction of New TB Vaccines for Adults and Adolescents was designed to support the planning, investments, and preparation for the rapid introduction and scale-up of TB vaccines for adults and adolescents so that…
The World Health Organization's Evidence Considerations for Vaccine Policy Development (ECVP) focuses on TB vaccines intended for adults and adolescents and is designed to support the product development, regulatory approval, introduction, access and widespread use in LMICs of new TB…
Informed by the acknowledged high need for new TB vaccines to support the fight to end TB, the World Health Organization's Preferred Product Characteristics outlines priority characteristics for TB vaccines in the short-term.
The World Health Organization's Catalyzing solutions for equitable global access and sustainable financing for novel tuberculosis vaccines for adults and adolescents report assesses country readiness, demand and supply projections, product development pathways and the global financing landscape to understand potential uncertainties…
From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL provides a first-of-its-kind analysis of the global supply chains of two key adjuvants used in several of the world’s most…
The 19th iteration of Treatment Action Group (TAG)'s Tuberculosis Research and Development Funding Report analyzes the state of play for dedicated TB R&D funding following the United Nations High Level Meeting on TB in September 2023. Significant acceleration of investment…
Communities and civil society organizations are poised to play an indispensable role in ensuring the success of new TB vaccines by building the “infrastructures of trust” that are foundational to vaccine acceptance, demand, and equitable access. What Could Go Right:…
Treatment Action Group’s 2024 Tuberculosis Vaccines Pipeline Report surveys major developments in the clinical development of new TB vaccines at this moment of scientific promise and political peril. The pipeline contains 17 candidates and covers vaccines that currently in Phase…
World Health Organization's investment case for new TB vaccines reviews the early evidence on the potential value of investing in the development and introduction of new TB vaccines to guide national and global decision-makers strategy.